GranuFlo Lawsuit | Granuflo Recall | NaturaLyte Recall Lawsuit
GranuFlo lawsuits are now being investigated by Wright & Schulte LLC on behalf of dialysis patients who suffered heart attacks, strokes, cardiac arrest and other life-threatening heart problems following administration of GranuFlo and NaturaLyte dialysis concentrates. Both of these drugs were used in thousands of dialysis clinics before they were linked to life-threatening heart side effects and subjected to a Class I GranuFlo recall. Mounting evidence suggests that Fresenius Medical Care, the manufacturer of GranuFlo and NaturaLyte, may have endangered the lives of thousands of dialysis patients by failing to warn of the dangers associated with these drugs when these risks first became apparent.
Dialysis patients, or their surviving family members, may be eligible to file a GranuFlo lawsuit if they experienced sudden heart problems during or shortly after undergoing a dialysis treatment that may have involved the administration of GranuFlo or NaturaLyte, including:
- Heart Attack
- Cardiopulmonary Arrest
- Dangerously Low Blood Pressure
- Sudden Cardiac Death
The GranuFlo Lawsuits Moving Forward In Federal Litigation
GranuFlo lawsuit claims filed since the GranuFlo recall are already moving forward in a federal litigation underway in Massachusetts. If you or a loved one were harmed by GranuFlo or NaturaLyte, filing a GranuFlo lawsuit could ensure that you obtain restitution for your medical bills, lost wages from inability to work, and pain and suffering. However, it’s important that you contact Wright & Schulte LLC as soon possible for a free, no obligation evaluation of your GranuFlo recall claim to ensure you are treated fairly and receive all of the compensation the law allows.
The GranuFlo Recall, NaturaLyte Recall
GranuFlo and NaturaLyte are both acid concentrates that serve the same function during dialysis, though GranuFlo is a dry product while NaturaLyte is a liquid. During dialysis, patients are administered these types of products to neutralize acid in the blood, a task their failing kidneys are unable to accomplish. Apparently, many doctors administering GranuFlo and NaturaLyte were not aware until the GranuFlo recall that the drugs contain more of an ingredient the body converts to bicarbonate than other products used for this purpose. Because doctors did not know to account for this difference, patients were in danger of experiencing a condition called metabolic alkalosis, which is associated with the occurrence of sudden, serious heart problems.
In March 2012, Fresenius Medical Care reported the serious risks associated with GranuFlo and NaturaLyte in an Urgent Product Notification that it sent to dialysis clinics throughout the country. In June of that year, the U.S. Food & Drug Administration (FDA) decided the issues with the drugs were serious enough to warrant Class I status, its most serious recall category. Since then, it has been revealed that Fresenius had been investigating the hazards associated with drugs long before the GranuFlo recall was announced. According to a company memo that was sent to its own dialysis clinics in November 2011, 941 patients treated at Fresenius’ centers had experienced cardiac arrest during 2010. The memo warned doctors to adjust the dosage of GranuFlo to avoid this danger. However, this vital administration was withheld from thousands of dialysis clinics outside of the Fresenius network that also used GranuFlo and NaturaLyte to treat patients.
FREE GranuFlo Lawsuit Consultations
Wright & Schulte LLC is offering free GranuFlo lawsuit consultations to victims of GranuFlo and NaturaLyte heart side effects. If you or a loved one suffered a heart attack, stroke, cardiac arrest or sudden cardiac death that could be associated with one of these drugs, please contact Wright & Schulte LLC today for your FREE GranuFlo lawsuit consultation by completing the online form on the right, or call toll free, 1-800-399-0795.
Other GranuFlo Lawsuit News
( fda.gov/MedicalDevices/Safety/ListofRecalls/ucm309990.htm, FDA, March 29, 2013 )
( In re Fresenius GranuFlo/Naturalyte Dialysate Litigation, MDL No. 2428 )